Posts Tagged ‘Medtronic’
Medtronic ranked #3 Holder of Pervasive Neurotech Intellectual Property*
One of the world’s largest medical technology companies, Medtronic manufactures devices to treat cardiovascular, diabetes, and musculoskeletal conditions, in addition to neurological conditions. Medtronic’s Neuromodulation business includes
Read MoreFirst-ever Pervasive Neurotechnology Report finds 10,000+ Patent Filings Transforming Medicine, Entertainment and Business
– Nielsen, Advanced Neuromodulation Systems, Medtronic, Microsoft and Brainlab emerge as leading IP holders . San Francisco, CA– (May 6, 2015) – SharpBrains, the leading market research firm tracking applied neuroscience, unveiled today–at the 2015 NeuroGaming Summit–a new 206-page report that, for the first time, analyzes the major intellectual property trends in the Pervasive Neurotechnology…
Read MoreUpcoming market report on Pervasive Neurotechnology
Just a quick heads-up to the SharpBrains community: we are wrapping up a comprehensive market report on Pervasive Neurotechnologies (non-invasive, scalable, potentially ubiquitous). To learn when it becomes available, keep tuned via our e‑Newsletter. See below, in alphabetical order, a few of the organizations to be profiled in the report, given their relevant intellectual property portfolios…
Read MoreTrend: Taking health (and brain health) care “beyond the pill”
. How Device Makers Can Take Healthcare “Beyond the Pill” (Medical Device and Diagnostic Industry): “One thing is clear: Pharma’s commitment to “beyond the pill” has never been so apparent. Each and every pharma company seems to have formed a division or a strategic team to explore new services around patient compliance, population health data…
Read More